Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2020 07:00 ET | Source: Novavax, Inc.

Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually

Serum Institute of India to manufacture ~1 billion doses of NVX-CoV2373 in 2021Increases global manufacturing capacity for NVX-CoV2373 to over 2 billion annualized doses when at full capacity in...
September 10, 2020 07:00 ET | Source: Novavax, Inc.

Novavax to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
September 02, 2020 17:14 ET | Source: Novavax, Inc.

Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine

GAITHERSBURG, Md., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
August 31, 2020 08:55 ET | Source: Novavax, Inc.

Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine

• Canadian government to purchase up to 76 million doses of NVX-CoV2373 GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company...
August 24, 2020 09:00 ET | Source: Novavax, Inc.

Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine

Primary objectives expand evaluation of immunogenicity and safetySecondary objectives include preliminary efficacy assessmentTrial to enroll up to 1,500 volunteers in United States and Australia, with...
August 17, 2020 02:30 ET | Source: Novavax, Inc.

Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa

Phase 2b clinical trial in collaboration with Professor Shabir Madhi and Wits UniversityBill & Melinda Gates Foundation providing $15 million grant toward trialMature trial infrastructure along...
August 14, 2020 01:07 ET | Source: Novavax, Inc.

Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate

UK government to purchase 60 million doses of NVX-CoV2373Novavax to partner with FUJIFILM Diosynth Biotechnologies to manufacture antigen component of NVX-CoV2373 in the UKNovavax and UK government to...
August 13, 2020 08:30 ET | Source: Novavax, Inc.

Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate

SK bioscience to manufacture antigen component of NVX-CoV2373Builds on and complements Novavax-CEPI collaboration to develop and distribute NVX-CoV2373Novavax, SK bioscience and Republic of Korea...
August 10, 2020 16:02 ET | Source: Novavax, Inc.

Novavax Reports Second Quarter 2020 Financial and Operational Results

Announced Positive Phase 1 data of Phase 1/2 clinical trial of NVX-CoV2373Secured $2 billion in funding for global coronavirus vaccine program through CEPI, DoD, and OWSExpanded large scale global...
August 07, 2020 05:26 ET | Source: Novavax, Inc.

Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

Novavax will license COVID-19 vaccine technology to Takeda for local production and commercialization in JapanMatrix-M adjuvant to be supplied from NovavaxGovernment of Japan will provide funding to...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right